Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DR26FCRF1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,944
Award facts
- Contract value 100% obligated
- $15,944.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $15,944.40 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, a contraceptive device, on October 28, 2025. The award was issued under a firm fixed-price structure with an ultimate completion date of November 19, 2025. DMS Pharmaceutical Group, a woman-owned small business headquartered in Park Ridge, Illinois, will perform the work at its facility location. This delivery order carries no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide recurring pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The parent contract, designated SPE2DR, was awarded to DMS Pharmaceutical Group on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. As a regional prime vendor contractor under this program, DMS Pharmaceutical Group supplies a comprehensive portfolio of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to support global military medical operations.
Quick answers
Who was awarded contract SPE2DR26FCRF1?
SPE2DR26FCRF1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FCRF1 worth?
The government has obligated $15,944 on SPE2DR26FCRF1.
Is contract SPE2DR26FCRF1 an order under another contract?
Yes. SPE2DR26FCRF1 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRF1 competed?
The extent of competition for SPE2DR26FCRF1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award